Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're barely eating on Mounjaro and the scales have stalled, under-fuelling is likely a bigger obstacle than overeating. Tirzepatide suppresses appetite so effectively that many people drift into a calorie intake too low to sustain healthy weight loss, triggering muscle loss, fatigue, and a slower metabolism. These are prescription-only medicines requiring full clinical assessment, and how much you eat on treatment matters as much as the medicine itself. Here's what the evidence says about getting the balance right.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It sounds logical. Mounjaro cuts your appetite, you eat almost nothing, the weight falls off faster. In practice, the opposite tends to happen. When calorie intake drops below roughly 800–1,000 kcal a day over weeks, your body responds by burning muscle tissue for fuel and dialling down its resting metabolic rate. That metabolic adaptation means you need fewer calories just to maintain weight, so when appetite eventually returns, even modest eating leads to rapid regain. Muscle loss is the hidden cost people rarely expect.
The NHS guidance on weight-management medicines is clear that treatment works best alongside a reduced-calorie diet, not a near-zero one. "Reduced" is doing real work in that phrase. Clinical trials used structured lifestyle programmes, not starvation. SURMOUNT-1, the main trial behind Mounjaro's UK licence, provided dietary counselling alongside the medicine, participants weren't just eating as little as possible.
A quick self-check worth doing: before your next meal, notice whether you're eating because you're mildly hungry or skipping meals entirely. If it's been more than five or six hours since you last ate and you've not felt hungry at all, tirzepatide may be suppressing appetite beyond a useful point. That's a conversation for your prescriber, not a reason to push through.
When appetite falls sharply on tirzepatide, total food volume drops, but the body's need for protein stays the same or increases, because muscle is now at greater risk of being used as fuel. Most clinical guidance for GLP-1 treatment suggests aiming for at least 1.2 grams of protein per kilogram of body weight daily, though the right amount for you is a conversation with a prescriber or registered dietitian. The practical challenge is fitting enough protein into smaller meals you may not feel motivated to eat.
This is where food choices shift in importance. If you only have appetite for a few hundred calories at a sitting, a bowl of plain crackers and a handful of grapes isn't the same as eggs, Greek yoghurt, or a small portion of fish. Our guide to what to eat on Mounjaro covers the specific foods that help you stay nourished on smaller portions. The same principle applies to fibre: it slows digestion, feeds gut bacteria, and keeps bowel function healthy when food volume falls, important because constipation is one of the more persistent side effects of tirzepatide, as noted on the NHS tirzepatide medicine page.
There is also a practical floor below which intake should not go without clinical supervision. Around 800 kcal is the level at which medical oversight is considered necessary in most clinical frameworks. If you're regularly eating less than that, our guide to calories on Mounjaro explains why that threshold matters and what to do if you're consistently falling below it, but the immediate response should still be to speak to your prescriber rather than assume it's fine because the medicine is working.
Signs that under-eating is becoming a clinical problem include: persistent fatigue that isn't explained by a dose increase, hair thinning or loss after the first couple of months of treatment, muscle weakness or difficulty with tasks you previously found easy, and weight loss that has plateaued or reversed despite continued treatment. None of these are automatic reasons to stop treatment, but all are reasons to review how treatment is going.
A prescriber at a service like ours can assess whether your appetite suppression is within a typical range, whether a dose adjustment is appropriate, and whether a referral to a dietitian would help. Tirzepatide doses are titrated gradually for a reason, the starter dose gives the body time to adjust, and moving up too fast when you're already barely eating can compound the problem. Every repeat order at nume is reviewed by a real clinician before dispatch, which is exactly the kind of checkpoint that catches this.
It's also worth knowing that eating patterns on Mounjaro often shift significantly over time, the extreme appetite suppression of early treatment usually softens at the maintenance dose, and building sustainable habits during that early phase makes a real difference later. If you're struggling to know how to structure your intake, our page on how many calories to aim for on Mounjaro sets out sensible ranges with context. The daily calorie guide breaks this down further by dose stage.
The cost of private treatment is a real consideration for many people (you can find context on Mounjaro pricing in the UK) but the value of clinical oversight is precisely in moments like this, where the medicine is doing something you didn't expect and the right response isn't obvious from the internet.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.